AN2 Therapeutics
ANTX
#9288
Rank
A$48.11 M
Marketcap
$1.61
Share price
1.42%
Change (1 day)
-93.55%
Change (1 year)

AN2 Therapeutics (ANTX) - Cash on Hand

Cash on Hand as of June 2024 : A$0.15 B

According to AN2 Therapeutics's latest financial reports the company has A$0.15 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AN2 Therapeutics - Cash on Hand chart (from 2021 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.14 B75.28%
2021-12-31A$80.53 M1424.68%
2020-12-31A$5.28 M